Bhandari, Jayant, Jordan Mah, Ritesh Daya, Rodney L. Johnson, and Ram K. Mishra. 2013. “Compound 186 Is a Negative Allosteric Modulator of Dopamine D2 Receptors: Implications for Improving Schizophrenia Therapy”. The Meducator 1 (22). https://doi.org/10.15173/m.v1i22.818.